Skip to main content
Figure 1 | Cardiovascular Diabetology

Figure 1

From: Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients

Figure 1

Changes in the plasma ANP and BNP levels following 12-week liraglutide treatment. ANP: A-type natriuretic peptides. BNP: B-type ventricular natriuretic peptides. (A) and (B): Changes in the plasma ANP and BNP levels at pre-treatment and post-treatment respectively. (C) and (D): Comparisons the increases in the ANP and BNP levels within two subgroups stratified by reductions of body weight loss: subjects who lost weight more than 5% and subjects who lost weight less than 5%.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840